Comments
Haemorrhagic septicaemia, a deadly bacterial disease that kills over 5 lakh cattle and buffalo in India, could soon be controlled. A consortium of global institutes, including Indian Immunologicals Ltd, have joined hands to develop a new vaccine over the next three years.
Current vaccines have achieved limited success in affording long-term protection. The new vaccine will be a genetically modified organism administered as vaccine. The consortia includes Inocul8 UK (the commercial interface of Moredun Research Institute, UK), Global Alliance for Veterinary Medicine (University of Glasgow, UK) and Indian Veterinary Research Institute.
The disease caused by the bacterium Pasteurella multocida has a major impact on the livestock industry in countries in south and southeast Asia. Young animals are at high risk.
Dr V.A. Srinivasan, Research Director at Indian Immunologicals, said, “An affordable, effective and improved vaccine for control of Haemorrhagic septicaemia is the need of the hour. The farming community will benefit immensely with the use of such a novel vaccine by preventing loss of animals due to the disease.”
The company is among India's top three animal-health players. It is among the few companies doing research to develop veterinary vaccines to address the needs of the livestock sector in the country.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.